Longeveron Inc (LGVN)

May 23, 2026

LGVN stock slips after hours as FDA flags concerns on rare heart defect trial design - MSN

May 23, 2026

May 22, 2026

LGVN Should I Buy - Intellectia AI

May 22, 2026

May 21, 2026

Longeveron CEO outlines strategy ahead of August trial data By Investing.com - Investing.com Nigeria

May 21, 2026

May 20, 2026

Longeveron CEO outlines strategy ahead of August trial data - Investing.com

May 20, 2026

May 20, 2026

[ARS] Longeveron Inc. SEC Filing - Stock Titan

May 20, 2026

May 20, 2026

Longeveron (NASDAQ: LGVN) plans reverse split, bigger share pool and incentive plan - Stock Titan

May 20, 2026

May 20, 2026

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering ... - Caledonian Record

May 20, 2026

May 20, 2026

Inside Longeveron’s stem-cell push on a deadly infant heart defect - Stock Titan

May 20, 2026

May 20, 2026

Longeveron anticipates August 2026 ELPIS II readout while shifting to an asset-light partnering model - MSN

May 20, 2026

May 19, 2026

Earnings call transcript: Longeveron Q1 2026 reveals strategic shift By Investing.com - Investing.com Nigeria

May 19, 2026

May 19, 2026

Earnings call transcript: Longeveron Q1 2026 reveals strategic shift - Investing.com

May 19, 2026

May 15, 2026

[SCHEDULE 13G] Longeveron Inc. Passive Investment Disclosure (>5%) - Stock Titan

May 15, 2026

May 15, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 15, 2026

May 14, 2026

Longeveron Earnings Call: Trial Milestones Amid FDA Hurdles - TipRanks

May 14, 2026

May 14, 2026

Longeveron Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 14, 2026

May 14, 2026

Longeveron Inc. (LGVN) Q1 2026 Earnings Call Transcript Summary - Moomoo

May 14, 2026

May 14, 2026

Longeveron Inc.Class A Common stock (NQ: LGVN - FinancialContent

May 14, 2026

May 14, 2026

Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update - BioSpace

May 14, 2026

May 13, 2026

LGVN: Q1 2026 featured stable revenue, lower expenses, and a pivotal HLHS trial readout expected in August - TradingView

May 13, 2026

May 13, 2026

Longeveron Intends to Seek Additional Financing Opportunities, Capital Raises >LGVN - Moomoo

May 13, 2026

May 13, 2026

Longeveron (LGVN) Q1 2026 Earnings Transcript - AOL.com

May 13, 2026

May 13, 2026

LGVN: Cash runway extended into Q4 2026 as focus shifts to key HLHS trial results and regulatory milestones - TradingView

May 13, 2026

May 13, 2026

Earnings call transcript: Longeveron Q1 2026 shows stability amid challenges By Investing.com - Investing.com Canada

May 13, 2026

May 13, 2026

Longeveron Q1 2026 Earnings Call: Complete Transcript - Yahoo Finance

May 13, 2026

May 13, 2026

Longeveron Q1 revenue rises, beats analyst estimates - TradingView

May 13, 2026

May 13, 2026

Longeveron (NASDAQ: LGVN) Q1 2026 loss, cash jump and stem cell pipeline - Stock Titan

May 13, 2026

May 13, 2026

Longeveron (LGVN) boosts cash with financing but flags going-concern risk - Stock Titan

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Longeveron Cut to Hold From Buy by Maxim Group - Moomoo

May 12, 2026

May 11, 2026

LGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - Stocktwits

May 11, 2026

May 11, 2026

Longeveron’s HLHS trial clears final safety review, data due August - Investing.com UK

May 11, 2026

May 11, 2026

LGVN SEC FilingsLongeveron Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 11, 2026

May 11, 2026

Longeveron’s HLHS trial clears final safety review, data due August By Investing.com - Investing.com South Africa

May 11, 2026